Lucius Sotorasib – Buy online
Sotorazib is a prescription drug that targets the KRAS G12C mutant protein. It received accelerated approval from the U.S. FDA on May 28, 2021. Patients should use it only as directed by their doctor.
View Product
Sotorasibu (Lumakras): What do patients need to know? – Oncodaily
Lumakras (Sotorasibu): What do patients need to know?
Full Article Content
Sotorasib (Lumakras) treats KRAS G12C-mutated cancers. Learn about uses, dosage, side effects, and expectation during treatment for patients, cancer treatment, Colorectal Cancer (CRC), Drugs, FDA Approved drugs, Lung cancer, NSCLC, OncoDaily, Oncology, Sotorasib
Products Mentioned in This Article
These products were automatically matched from the article title, summary, and full content.
SOTOLDX Sotorasib 120mg
On May 29, 2021, the U.S. FDA announced accelerated approval for sotorasib (AMG510) for the treatment of patients with non-small cell lung cancer (NSCLC) harboring KRAS G12C mutations. These patients had received at least one prior systemic therapy. This is the world's first anticancer therapy targeting a specific KRAS gene mutation.
View Product
Frequently Asked Questions
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Sotorasib – Buy online、SOTOLDX Sotorasib 120mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
